2003
Invitation to Submit Abstracts
The Program Committee is committed to
presenting the broadest possible range of high quality
work from the membership at the 2003 PAS Annual Meeting.
We would like both the absolute number of abstracts
presented, and the percentage accepted, to grow. To
achieve these goals while preserving the quality of the
Meeting, we ask members sponsoring each abstract to pay
close attention to the abstract content. Historically,
abstracts accepted for presentation are hypothesis-driven
new work. Abstracts rarely accepted for presentation
include single case reports, open label drug trials,
highly speculative accounts of clinical experience, and
op-ed accounts of personal experience. Interim results
from an ongoing clinical trial will not be accepted for
presentation unless the study has been prematurely closed
for efficacy, lack of efficacy, or issues of safety. The
submission of multiple, similar abstracts from the same
investigator(s) or laboratory are strongly discouraged.
The member sponsoring each abstract
is the first and most important part of the review and
selection process. Please contribute to the Meeting
quality and do not sponsor an abstract you would not like
to see on the program.
ABSTRACT SELECTION
PROCESS
Abstracts of superior quality will be
selected by the PAS Program Committee for presentation at
the Meeting in Seattle, Washington. Abstracts will be
graded based on quality, scientific merit/importance, and
quality of research, design and data analysis and the
quality of presentation. The submission of abstracts
without data because investigations or analyses are
incomplete and will be evaluated only on the basis of the
information contained in the abstract.
Designation of a Theme Choice and the
listing of key words are essential for the program
committee to determine/select abstracts that can be
grouped for presentation in poster symposia and other
thematic sessions. Choice of abstracts for these thematic
sessions is the very first step in the development of the
program, and these sessions often include the most highly
rated abstracts. Therefore, it is in your interest to
designate a theme whenever possible. Key words will be
used as the second step in development of the program to
encourage groups of abstracts for presentation among those
authors with similar scientific or clinical interests,
regardless of subspecialty. Subspecialty topic designation
will be the last criterion used in the program
development.
AWARD CONSIDERATION
AND SELECTION
The American Pediatric Society, Society
for Pediatric Research, Ambulatory Pediatric Association,
and American Society of Pediatric Hematology/Oncology seek
nominations for awards through the abstract submission
process. Information regarding the awards for 2003, their
eligibility criteria, and the award process can be in the Awards
section.
Please review these criteria and apply
for any award for which you believe you are eligible and
would like to be considered. Only abstracts accepted for
presentation are considered for awards.
Application for an award involves
submitting an abstract, checking the appropriate box in
the "Questionnaire" part of the submission
program, completing the Award Application Form for the
respective award, and including the required supplemental
materials (as indicated in the award information and on
the Application Form).
While you are welcome to apply for more
than one award, an Award Application Form is required for
EACH award for which you have indicated an interest (by
checking the box in the "Questionnaire").
TRAVEL GRANTS
The Society for Pediatric Research and
American Pediatric Society will award travel grants in the
amount of $500 plus complimentary meeting registration to
attend the 2003 PAS Annual Meeting. Travel grants are
possible to at least fifteen runner-ups among the
SPR House Officer and Fellow Basic and Clinical and
Richard D. Rowe Award categories. To be considered for a
travel award, check the appropriate box in the
"Questionnaire" part of the submission program
and on the Award Application Form. (Only candidates
submitting to the SPR House Officer and Fellow Basic and
Fellow Clinical and Richard D. Rowe award categories will
be considered.)
PRESENTATION FORMATS
The Program Committee determines the
appropriate format for presentation (platform, poster, or
poster symposium). Platform sessions will be 2 hours and
will consist of 15-minute presentations (10 minutes for
the presentation; 5 minutes for discussion). Poster
symposia will be 2 hours and include both a poster with a
viewing period and a formal presentation or discussion
period. The session moderators determine formats for
formal presentation or discussion. Poster sessions will be
2-3 hours. Detailed instructions for the preparation of
slides and posters as well as scheduling notices will be
mailed to the contact person in advance of the Meeting.
Platform, poster symposia, and poster guidelines will also
be available on this website. The complete schedule of all
abstract presentations will be finalized by mid February
2003.
PUBLICATION OF
ABSTRACTS
ALL abstracts submitted for
consideration to the PAS Annual Meeting will be published
in the 2003 Pediatric Research -
Program/Proceedings (April issue) regardless of
presentation status. The journal will be issued to Pediatric
Research subscribers. Other registrants can purchase
the proceedings through registration for the PAS Annual
Meeting.
Hematology/Oncology Abstracts:
All abstracts submitted to the Hematology or Oncology
subspecialties for consideration by the program committee
will be published in the 2003 March/April issue of the Journal
of Pediatric Hematology/Oncology, regardless of
presentation status. The journal is sent to the Journal
of Pediatric Hematology/Oncology subscribers and to
members of the American Society of Pediatric
Hematology/Oncology (ASPH/O). All registrants for the ASPH/O
meeting will receive a copy of the abstract issue of the Journal
of Pediatric Hematology/Oncology as part of their
registration materials.
Deadline for receipt
of all abstract submissions is
December 6, 2002, 11:59 PM CST.
(extended to December 11th, 5:00pm CST, owing to weather and
power outages)
The deadline for submission of
abstracts is absolute. Late submissions will not
be accepted for consideration in regular program
planning. The signed copy, payment, and other
supplemental materials must be received by
December 10, 2002.
|
GENERAL POLICIES
- Electronic Submission Deadline is December
6, 2002, 11:59 PM CST (extended to December
11th, 5:00pm CST, owing to weather and
power outages)
- A fee of $40.00 is required for each
abstract submitted.
- Only abstracts submitted using the
OFFICIAL electronic submission program or on OFFICIAL
2003 PAS abstract forms will be accepted.
- All abstracts should be submitted in
a structured format.
- All abstracts must be sponsored (and
signed) by a member of one of the sponsoring
organizations for the 2003 Meeting (APS, SPR, or APA)
and submitted using the 2003 OFFICIAL electronic
submission program or 2002 OFFICIAL abstract form. The
sponsoring member must be in good standing (dues
current) or the abstract will not be considered.
The sponsor does not have to be an author.
- There is no limit on the number of
abstracts submitted by each member or sponsor, but the
submission of multiple, similar abstracts from the
same investigator(s) or laboratory is strongly
discouraged.
- Of Special note:
Members of The American Society of Pediatric
Hematology/Oncology (ASPH/O) may sponsor abstracts
when submitted to the Hematology or Oncology
subspecialties.
- Abstracts submitted or presented to
other societies or national meetings can be
submitted for consideration for the PAS Meeting.
- Research published in
manuscript form prior to the submission of the
abstract is not appropriate and should not be
submitted. If data contained in the abstract is
published after submission of the abstract, the
Central Office must be notified regardless of timing
as soon as publication is recognized. At that time a
member of the program committee will make a
determination concerning presentation.
- Conflict of Interest/Disclosure: Work
submitted for presentation must include an
acknowledgment of funding sources of commercial nature
and/or consulting or holding of significant equity in
a company that could be affected by the results of the
study. The intent of this policy is not to prevent a
speaker with a potential conflict of interest from
making a presentation. It is merely intended that any
potential conflict should be identified openly so that
the listeners may form their own judgments about the
presentation with the full disclosure of the facts. Even
if indicated elsewhere in the abstract, this must
appear as the last sentence of the abstract and read
"funded by..." and/or "equity
in..." if pertinent. (See Step 4 - Disclosure
Info.)
- The first author must sign the
abstract and attest that all authors have approved the
submission of the work for presentation.
- Any animal studies must conform with
the "Guiding Principles in the Care and Use of
Animals" of the American Physiological Society
and any human experimentation has been conducted
according to a protocol approved by the institutional
committee on ethics of human investigation. And, if no
such committee exists, that it conforms with the
principles of the Declaration of Helsinki of the World
Medical Association (Clinical Research 14:193, 1966).
- If the abstract is selected, the
presentation must include the methods used for study
and any other information relevant to research.
ABSTRACT SUBMISSION
FEE
The $40.00 per abstract payment can be made
directly online or by printing a special payment form. The
Official Electronic Printed Abstract and the Payment Form
can be printed and signed after submitting the abstract. The
signed copy, payment and supplemental materials must be
received by December 10, 2002. (extended
to December 12th)
NOTIFICATION OF
RECEIPT AND ACCEPTANCE
Notification of receipt will be e-mailed to
the contact author within 2 business days of abstract
receipt. NOTE: It is your responsibility to contact
Marathon Multimedia (contact information below) if you do
not receive confirmation of abstract receipt within 2
business days. They will be able to confirm receipt of
your abstract or will assist you to ensure that your
abstract is received.
Marathon Multimedia
Telephone: (507) 334-5212
Facsimile: (507) 334-0126
Email: support@marathonmultimedia.com
Notification of abstract acceptance
status will be emailed to the contact author by February
15, 2003. If you have not received notification by
February 17, 2003, please contact the PAS Program Office
at (281) 419-0052 or email (info@pas-meeting.org)
for additional assistance.
IMPORTANT
- Electronic abstracts must be
submitted by December 6, 2002, 11:59 PM, Central
Standard Time.
- You must print, and return a copy of
the Official Electronic Abstract Printout and the
payment form (if not paid online) by December 10,
2002.
- The official abstract printout must
include the signature of both the sponsor and first
author.
- If you wish the abstract to be
considered for an award, the supplemental materials
[including the Award Application Form(s)] must be
submitted with the signed official printout you send
by December 10.
Send to the following address:
PAS Abstracts
c/o Marathon Multimedia
1201 West Division St.
Faribault, MN 55021
Telephone: (507) 334-5212 Facsimile:
(507) 334-0126
Email: support@marathonmultimedia.com
| Don't Forget to Fax or Send
a Copy of What You Submitted Electronically:
If you submit your file
electronically and are using a credit card for
payment, you may fax in the signed Official
Electronic Abstract Printout. If you fax copies,
please test to make sure that your fax machine is
in good working order and can send a legible copy
of your abstract.
This crucial step also assures
you we really have received your electronic
submission.
NOTE Regarding Figures: If
your abstract contains a figure, you must send
a clean black and white copy of the figure for
inclusion in the Abstract Book.
|
Submission
Mailing Address, Telephone, Facsimile, and Email:
PAS Abstracts
c/o Marathon Multimedia
1201 West Division St.
Faribault, MN 55021
Telephone: (507) 334-5212
Facsimile: (507) 334-0126
Email: support@marathonmultimedia.com
|
